Hill, A., McBride, A., Sawyer, A.W., Clumeck, N. and Gupta, R.K. (2013) Resistance at Virological Failure Using Boosted Protease Inhibitors versus Non-Nucleoside Reverse Transcriptase Inhibitors as First-Line Antiretroviral Therapy Implications for Sustained Efficacy of ART in Resource-Limited Settings. The Journal of Infectious Diseases, 207, S78-S84.
http://jid.oxfordjournals.org/content/207/suppl_2/S78.full.pdf

has been cited by the following article:

• TITLE: HIV-1 Drug Resistance Mutations in Patients Failing 1st Line Therapy in a Comprehensive Care Center in Nairobi, Kenya

  AUTHORS: Elizabeth Luvai, Rebecca Waihenya, James Munyao, Lucy Sanguli, Christina Mwachari, Samoel Khamadi

  KEYWORDS: HIV-1, Treatment Failure, Antiretroviral Therapy, Drug Resistance, Subtype

  JOURNAL NAME: World Journal of AIDS, Vol.5 No.2, June 3, 2015

  ABSTRACT: Background: HIV-1 drug resistance is an emerging challenge for HIV-1 infected clients who are on antiretroviral therapy (ART). In Kenya, as in many other developing countries, ART is now accesible to clients who need it. However, they must be done a CD4 test first and if the count is